Encompass Health Corporation which can be found using ticker (EHC) now have 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘strong_buy’. The target price High/Low ranges between $120.00 and $105.00 suggesting an average Analsyt target price of $115.25. Now with the previous closing price of $103.53 and the analysts are correct then there would likely be a percentage uptick in value of 11.3%. The 50 day MA is $95.52 while the 200 day moving average is $85.71. The total market capitalization for the company now stands at 10.40B. The current share price for the company is: $103.20 USD
The potential market cap would be $11,574,426,325 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 24.28, revenue per share of $52.26 and a 8.38% return on assets.
Encompass Health Corporation is a provider of post-acute healthcare service. The Company manages its operations through its inpatient rehabilitation segment. The Company is the owner and operator of rehabilitation hospitals. It operates hospitals in approximately 37 states and Puerto Rico, with concentrations in the eastern half of the United States and Texas. The Company operates approximately 156 inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on an inpatient basis. The Company’s inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It also provides rehabilitative care for patients recovering from injury or illness, using advanced technology and treatments to maximize recovery. Its hospitals provide a comprehensive interdisciplinary clinical approach to treatment that leverages technologies and advanced therapies and leads to superior outcomes.
